熱門資訊> 正文
LifeVantage 2025年第二季度盈利预览
2025-02-05 06:35
- LifeVantage (NASDAQ:LFVN) is scheduled to announce Q2 earnings results on Wednesday, February 5th, after market close.
The consensus
EPS Estimate is $0.13 (+30.0% Y/Y) and the consensus Revenue Estimate is $67.41M (+30.6% Y/Y).Over the last 2 years, LFVN
has beaten EPS estimates 63% of the time and has beaten revenue estimates 50% of the time.Over the last 3 months, EPS estimates have seen 1
upward revision and 0 downward. Revenue estimates have seen 1 upward revision and 0 downward.
- Recent earnings Analysis from our contributors:LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
More on LifeVantage
- LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
- LifeVantage soars after seeing a sales boost from its GLP-1 product
- LifeVantage expects Q2 revenue of about $67.5M, raises FY25 sales guidance
- Seeking Alpha’s Quant Rating on LifeVantage
- Historical earnings data for LifeVantage
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。